Bionano Genomics (BNGO) Gains from Sales and Divestitures (2025 - 2026)
Bionano Genomics' (BNGO) quarterly Gains from Sales and Divestitures came in at $360.0 in Q1 2026, down 79.31% quarter-over-quarter from $1740.0 in Q4 2025.
Bionano Genomics (BNGO) Gains from Sales and Divestitures (2025 - 2026) Analysis & Trends
Bionano Genomics has disclosed Gains from Sales and Divestitures across 2 years of filings, most recently posting $360.0 for Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $360.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $360.0 (changed N/A YoY), and the FY2025 annual result was $1740.0, changed N/A from the prior year.
- Gains from Sales and Divestitures came in at $360.0 for Q1 2026 at Bionano Genomics, down from $1740.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $1740.0 in Q4 2025 to a low of $360.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Bionano Genomics | 14.01 Mn | -366,620.40 | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 360.00 |
| Mar 31, 2026 | 360.00 |
| Dec 31, 2025 | 1,740.00 |
| Dec 31, 2025 | 1,740.00 |